Drugs Pharma

FDA expands approval of kidney cancer drug to earlier-stage patients

HQ Team June 16, 2026: The US Food and Drug Administration (FDA) has expanded approval of belzutifan, a first-in-class kidney cancer drug, to.

Read More
Drugs Health Pharma

USFDA green lights Merck’s drug to treat advanced kidney cancer 

HQ Team December 15, 2023: Merck announced it got USFDA approval for its belzutifan drug, branded as Welireg, to treat an advanced form.

Read More